Accueil
> Essais thérapeutiques
> REIN
REIN
16 juillet 2016
REIN? : Ramipril Efficacy in Nephropathy.
The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet. 1997 Jun 28 ;349(9069):1857-63. 9217756
Ramipril Efficacy in Nephropathy. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril : REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Lancet.1998 Oct 17 ;352(9136):1252-6. 9788454
Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2) : multicentre, randomised controlled trial.
Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G ; REIN-2 Study Group. Lancet. 2005 ; 365(9463):939-46. 15766995
Ruggenenti P, Perna A, Remuzzi G ; GISEN Group Investigators. Retarding progression of chronic renal disease : the neglected issue of residual proteinuria. Kidney Int. 2003 Jun ; 63(6):2254-61. 12753315
Ruggenenti P, Perna A, Remuzzi G ; Gruppo Italiano di Studi Epidemiologici in Nefrologia. ACE inhibitors to prevent end-stage renal disease : when to start and why possibly never to stop : a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy. J Am Soc Nephrol.2001 Dec ;12(12):2832-7. 11729254
Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G. Chronic proteinuric nephropathies : outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. Am J Kidney Dis. 2000 Jun ; 35(6):1155-65. 10845831
Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G.Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999 ; 354(9176):359-64. 10437863
Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999 ; 354(9176):359-64. 10437863
Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN). Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int.1998 May ;53(5):1209-16. 9573535
